Protection of Ovarian Function in Female Patients With Hodgkin Lymphoma
This study is designed to test the the protective capacity of Goserelin compared with oral contraceptive
Hodgkins Lymphoma
DRUG: 8 cycles BEACOPPesc plus oral contraceptive|DRUG: 8 cycles BEACOPPesc plus Goserelin
FSH level 6 month after end of treatment, 6 month
This study is designed to test the the protective capacity of Goserelin compared with oral contraceptive